123 related articles for article (PubMed ID: 9666865)
1. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
Greenman Y; Tordjman K; Stern N
Clin Endocrinol (Oxf); 1998 May; 48(5):547-53. PubMed ID: 9666865
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.
Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S
Nat Rev Endocrinol; 2023 Dec; 19(12):722-740. PubMed ID: 37670148
[TBL] [Abstract][Full Text] [Related]
3. Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size.
Burke WT; Penn DL; Castlen JP; Donoho DA; Repetti CS; Iuliano S; Barkhoudarian G; Laws ER
J Neurosurg; 2019 Jun; 133(2):321-328. PubMed ID: 31200381
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility.
Huber M; Luedi MM; Schubert GA; Musahl C; Tortora A; Frey J; Beck J; Mariani L; Christ E; Andereggen L
Front Surg; 2024; 11():1363431. PubMed ID: 38544490
[TBL] [Abstract][Full Text] [Related]
5. Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population.
Chentli F; Azzoug S; Daffeur K; Akkache L; Zellagui H; Haddad M; Kalafate N
Indian J Endocrinol Metab; 2015; 19(3):359-63. PubMed ID: 25932390
[TBL] [Abstract][Full Text] [Related]
6. Emotional aspects of hyperprolactinemia.
Sobrinho LG
Psychother Psychosom; 1998; 67(3):133-9. PubMed ID: 9667060
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinaemia and pituitary adenomas in adolescence.
Dissaneevate P; Warne GL
J Pediatr Endocrinol Metab; 1998; 11(4):531-41. PubMed ID: 9777574
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center.
Hofbauer S; Horka L; Seidenberg S; Da Mutten R; Regli L; Serra C; Beuschlein F; Erlic Z
Front Endocrinol (Lausanne); 2024; 15():1363939. PubMed ID: 38645431
[TBL] [Abstract][Full Text] [Related]
9. Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy.
Andereggen L; Christ E
Front Endocrinol (Lausanne); 2024; 15():1371468. PubMed ID: 38510701
[No Abstract] [Full Text] [Related]
10. Correlation of serum prolactin with sleep duration, wake-up hour, and phases of the menstrual cycle in healthy adult subjects.
Abdulateef DS
Sleep Biol Rhythms; 2023 Jul; 21(3):319-327. PubMed ID: 38469081
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Abnormalities, Inflammatory Markers and Endothelial Dysfunction in Hyperprolactinemia due to Prolactinoma before and after Normalization of Serum Prolactin: A Prospective Case Control Study.
Baba MS; Laway BA; Misgar RA; Wani AI; Bashir MI; Bhat IA; Haq MG; Shah ZA
Indian J Endocrinol Metab; 2023; 27(4):357-364. PubMed ID: 37867992
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabidiol on weight and fasting blood sugar with chronic and subchronic haloperidol administration.
Kajero JA; Seedat S; Ohaeri JU; Akindele A; Aina O
Discov Ment Health; 2022 Jul; 2(1):18. PubMed ID: 37861864
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.
Krysiak R; Basiak M; Machnik G; Szkróbka W; Okopień B
Nutrients; 2023 May; 15(10):. PubMed ID: 37242186
[TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study.
Krysiak R; Kowalcze K; Okopień B
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176648
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions.
Chien HY; Chen SM; Li WC
Front Clin Diabetes Healthc; 2023; 4():935872. PubMed ID: 36993818
[TBL] [Abstract][Full Text] [Related]
16. Ectopic lipid metabolism in anterior pituitary dysfunction.
Baumgartner C; Krššák M; Vila G; Krebs M; Wolf P
Front Endocrinol (Lausanne); 2023; 14():1075776. PubMed ID: 36860364
[TBL] [Abstract][Full Text] [Related]
17. Effects of Anterior Pituitary Adenomas' Hormones on Glucose Metabolism and Its Clinical Implications.
Li M; Zhang J; Yang G; Zhang J; Han M; Zhang Y; Liu Y
Diabetes Metab Syndr Obes; 2023; 16():409-424. PubMed ID: 36816815
[TBL] [Abstract][Full Text] [Related]
18. Prolactinomas in adolescent and elderly patients-A comparative long-term analysis.
Andereggen L; Tortora A; Schubert GA; Musahl C; Frey J; Luedi MM; Mariani L; Beck J; Christ E
Front Surg; 2023; 10():967407. PubMed ID: 36814862
[TBL] [Abstract][Full Text] [Related]
19. The interplay between prolactin and cardiovascular disease.
Glezer A; Santana MR; Bronstein MD; Donato J; Jallad RS
Front Endocrinol (Lausanne); 2022; 13():1018090. PubMed ID: 36704037
[TBL] [Abstract][Full Text] [Related]
20. Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis.
Rassie K; Giri R; Joham AE; Mousa A; Teede H
Front Endocrinol (Lausanne); 2022; 13():1069625. PubMed ID: 36619539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
